Skip to main content

Table 7 Summary of studies on imaging for evaluation of treatment

From: Imaging for Dupuytren disease: a systematic review of the literature

Study (year)

Design

Level of evidence

Imaging modality

N (hands)

Clinical details

Outcome parameters

Results

Additional value MRI

Additional value US

Christie (2011) [36]

Case-report

5

US

1 (1)

A 42-year-old patient undergoing cross-frictional therapy (8 weeks)

- Visible changes: US + clinical examination

- ROM

- Symptoms (subjective)

- US: no observed subcutaneous changes

- Clinical examination: decreased nodule size, skin wrinkling and contractile bands

- Increased ROM

- Reduced patient-reported symptoms

–

No

Yin (2016) [37]

Prospective cohort study

3

US

37 (49)

Dupuytren patients undergoing injection of triamcinolone acetonide in nodules. Follow-up: 5 years.

- Nodule size on US

- Complications

- nodule size: reduction of 40% at 6 months and 56% at 5 years.

- complications: none

–

Yes

Banks (2017) [38]

Retrospective cohort study

4

MRI

6 (8)

Patients with superficial fibromatoses of the hand and feet undergoing EBT

Follow-up 4.5 months.

- Nodule volume on MRI

- MRI signal intensity

- Pain (VAS-score)

- Volume: significant decrease from 1.5 to 1.2 cm3

- Signal intensity: significant decrease

- Pain: decrease in VAS-score in patients with high pre-treatment signal intensity

Yes

–

Strömberg (2017) [39]

Prospective cohort study

3

US

39

19 patients undergoing CCH, 20 patients undergoing PNF.

Follow-up 1 year.

- Gap-width measured with US

- Correction of MCP-joint

- Recurrence

- Gap-width (median) 18 mm for both groups

- MCP-correction (median): PNF 46° and CCH 53°

- Recurrence: n = 1

Yes

 

Crivello (2015) [40]

Prospective cohort study

4

MRI

5 (5)

5 DD patients undergoing CCH in 5 fingers. Follow-up 30 days.

- MRI signal intensity

- Cord volume

- MRI signal intensity: significant increase (320%)

- Cord volume: significant decrease (72%)

Yes

 
  1. US ultrasound, MRI magnetic resonance imaging, DD Dupuytren disease, PNF percutaneous needle fasciotomy, CCH collagenase clostridium hystoliticum, EBT electron-beam therapy, MCP metacarpophalangeal, ROM range of motion, VAS visual analogue scale